Search results for "pathogenesis"

showing 10 items of 761 documents

Oral lichen planus after certolizumab pegol treatment in a patient with Crohn's disease

2011

Dear Sir , Lichen planus (LP) is a relatively uncommon inflammatory dermatosis of the mucocutaneous surfaces that can present with a variety of clinical manifestations and, most commonly, affecting middle-aged adults. The disease course may be short or chronic, although most cases may resolve after 1 month to 7 years. The real prevalence of LP is unknown, but is estimated to be 1% in the USA.1 The pathogenesis of LP is not entirely understood. In general, activated T lymphocytes are recruited to the dermal–epidermal junction and induce apoptosis in basal keratinocytes. Both CD4+ and CD8+ T lymphocytes are found in the lichenoid infiltrate of LP, with a predominance of the latter cell type b…

education.field_of_studyCrohn's diseasemedicine.medical_specialtySettore MED/09 - Medicina Internaintegumentary systembusiness.industryPopulationMucocutaneous zoneoral lichen planu certolizumab crohnGastroenterologyGeneral Medicinemedicine.diseaseDermatologyPathogenesisstomatognathic diseasesBasal (phylogenetics)medicineOral lichen planusCertolizumab pegoleducationbusinessCD8medicine.drugJournal of Crohn's and Colitis
researchProduct

OP0042 BLOCKING OF CD103+ TISSUE RESIDENT MEMORY T CELLS (TRM) AS A THERAPEUTIC STRATEGY IN SJOGREN’S SYNDROME

2021

Background:Tissue-resident memory T cells (TRM), are a recently identified T cells population featuring tissue localization and expression of markers of tissue homing, CD69 and CD103. Recently, the expansion of CD8+ TRMs and their involvement in the sialadenitis was described in a murine model of SS. However, CD4+ and CD8+ TRM’s functional relevance in pSS is still not fully understood, and the TRM therapeutic targeting unexplored.Objectives:The study aimed to address the role of CD4+ and CD8+ TRMs in the pathogenesis of pSS and to explore the therapeutic targeting of the tissue residency marker of TRM CD103.Methods:An animal model of experimental (ESS) obtained by immunization of female C5…

education.field_of_studymedicine.diagnostic_testSalivary glandbusiness.industryImmunologyPopulationmedicine.diseaseSialadenitisGeneral Biochemistry Genetics and Molecular BiologyFlow cytometryPathogenesismedicine.anatomical_structureRheumatologySicca syndromemedicineCancer researchImmunology and AllergyImmunohistochemistryeducationbusinessCD8Annals of the Rheumatic Diseases
researchProduct

Autoimmune thyroid disease: new models of cell death in autoimmunity

2002

Autoimmunity to thyroid antigens leads to two distinct pathogenic processes with opposing clinical outcomes: hypothyroidism in Hashimoto's thyroiditis and hyperthyroidism in Graves' disease. The high frequency of these diseases and easy accessibility of the thyroid gland has allowed the identification of key pathogenic mechanisms in organ-specific autoimmune diseases. In early investigations, antibody- and T-cell-mediated death mechanisms were proposed as being responsible for autoimmune thyrocyte depletion. Later, studies on apoptosis have provided new insights into autoimmune target destruction, indicating the involvement of death receptors and cytokine-regulated apoptotic pathways in the…

endocrine systemHistoryProgrammed cell deathFas Ligand Proteinendocrine system diseasesImmunologyThyroid GlandApoptosisAutoimmunityDiseasemedicine.disease_causeThyroiditisEducationAutoimmunityPathogenesisAntigenSettore MED/04 - PATOLOGIA GENERALEHumansMedicinefas ReceptorMembrane Glycoproteinsbiologybusiness.industryThyroidThyroiditis Autoimmunemedicine.diseaseGraves DiseaseComputer Science Applicationsmedicine.anatomical_structureModels AnimalImmunologybiology.proteinAntibodybusinessT-Lymphocytes CytotoxicNature Reviews Immunology
researchProduct

Evaluation of presumptive biomarkers of oxidative stress, immune response and apoptosis in primary open-angle glaucoma.

2013

There is growing interest on the correlation among oxidative stress, inflammation, apoptosis and primary open-angle glaucoma initiation and progression. Reactive oxygen species are formed in the eyes following a wide variety of stressors, and are largely implicated in glaucoma pathogenesis. Immune-inflammatory response mediators have recently become a target of ophthalmologic concern, including glaucoma. Much attention has been derived to the role of specific pro and anti-apoptotic molecules in glaucoma. This article reviews the early evidence suggesting that reactive oxygen species, immune inflammatory response mediators, and apoptogenic molecules are engaged in glaucoma disease. Moreover,…

genetic structuresOpen angle glaucomaGlaucomaInflammationApoptosisDiseaseBiologymedicine.disease_causePathogenesisImmune systemDrug DiscoverymedicineAnimalsHumansPharmacologychemistry.chemical_classificationInflammationReactive oxygen speciesmedicine.diseaseeye diseasesOxidative StresschemistryImmunologysense organsmedicine.symptomOxidative stressBiomarkersGlaucoma Open-AngleCurrent opinion in pharmacology
researchProduct

The role of neuroinflammation in the pathogenesis of glaucoma neurodegeneration

2020

The chapter is a review enclosed in the volume "Glaucoma: A pancitopatia of the retina and beyond." No cure exists for glaucoma. Knowledge on the molecular and cellular alterations underlying glaucoma neurodegeneration (GL-ND) includes innovative and path-breaking research on neuroinflammation and neuroprotection. A series of events involving immune response (IR), oxidative stress and gene expression are occurring during the glaucoma course. Uveitic glaucoma (UG) is a prevalent acute/chronic complication, in the setting of chronic anterior chamber inflammation. Managing the disease requires a team approach to guarantee better results for eyes and vision. Advances in biomedicine/biotechnolog…

genetic structuresbusiness.industryNeurodegenerationGlaucomaDiseasemedicine.diseaseNeuroprotectioneye diseasesPathogenesis03 medical and health sciences0302 clinical medicineUveitic glaucomaMedicinesense organsbusinessNeuroscience030217 neurology & neurosurgeryNeuroinflammationBiomedicine
researchProduct

Should inflammatory pathways be targeted for the prevention and treatment of hypertension?

2019

Hypertension is the most common modifiable risk factor for cardiovascular disease (CVD)1 and is a leading cause of death globally.2 Hypertension and CVD share common antecedent risk factors which include physical inactivity, obesity and excess alcohol intake.3 Though these established risk factors explain a large proportion of hypertension risk, its pathogenesis is still not fully established as it appears that other additional lifestyle and genetic factors may be involved. There is therefore a need to identify and evaluate putative risk factors that may increase our knowledge of hypertension development, may have causal or predictive relevance, and which will help develop preventive and ma…

hypertensionInflammationsystemic reviewDisease030204 cardiovascular system & hematologyBioinformaticsFibrinogenArticleProinflammatory cytokineCohort StudiesPathogenesis03 medical and health sciences0302 clinical medicinemedicineHumans030212 general & internal medicineRisk factorAntihypertensive AgentsCause of deathInflammationbusiness.industryinflammatory markersmeta-analysisMeta-analysisHypertensionepidemiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drugHeart
researchProduct

Cardiorenal Syndrome: New Pathways and Novel Biomarkers

2021

Cardiorenal syndrome (CRS) is a multi-organ disease characterized by the complex interaction between heart and kidney during acute or chronic injury. The pathogenesis of CRS involves metabolic, hemodynamic, neurohormonal, and inflammatory mechanisms, and atherosclerotic degeneration. In the process of better understanding the bi-directional pathophysiological aspects of CRS, the need to find precise and easy-to-use markers has also evolved. Based on the new pathophysiological standpoints and an overall vision of the CRS, the literature on renal, cardiac, metabolic, oxidative, and vascular circulating biomarkers was evaluated. Though the effectiveness of different extensively applied biomark…

kidneyrenal injuryDiseaseCardiorenal syndromeReviewheartBioinformaticsBiochemistryMicrobiologyPathogenesisRenal injuryotorhinolaryngologic diseasesMedicineHumansNGALKIM-1Molecular Biologycardiorenal syndromeKidneymicroRNACardio-Renal Syndromebusiness.industryAcute kidney injuryChronic injurymedicine.diseasechronic renocardiac syndromenovel biomarkersPrognosisQR1-502proBNPCirculating biomarkersmedicine.anatomical_structureacute kidney injurybusinessAcute kidney injury; Cardiorenal syndrome; Chronic renocardiac syndrome; Heart; Kidney; KIM-1; MicroRNA; NGAL; Novel biomarkers; ProBNP; Renal injuryBiomarkersBiomolecules
researchProduct

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications

2018

Antiphospholipid syndrome (APS) is an acquired autoimmune disease characterized by thromboembolic events, pregnancy morbidity, and the presence of antiphospholipid (aPL) antibodies. There is sound evidence that aPL act as pathogenic autoantibodies being responsible for vascular clots and miscarriages. However, the exact mechanisms involved in the clinical manifestations of the syndrome are still a matter of investigation. In particular, while vascular thrombosis is apparently not associated with inflammation, the pathogenesis of miscarriages can be explained only in part by the aPL-mediated hypercoagulable state and additional non-thrombotic effects, including placental inflammation, have b…

lcsh:Immunologic diseases. Allergy0301 basic medicineImmunologyComplementMiscarriagesAnti-beta2 glycoprotein I antibodieInflammationMiscarriagePathogenesis03 medical and health sciences0302 clinical medicineImmune systemAntiphospholipid syndromeimmune system diseasesAntiphospholipid syndromeMedicineImmunology and AllergyAnimal model030203 arthritis & rheumatologyAutoimmune diseaseInflammationbusiness.industryAutoantibodyThrombosismedicine.diseaseComplement (complexity)Complement systemAnimal models030104 developmental biologyAnti-beta2 glycoprotein I antibodiesPerspectiveThrombosiImmunologyAnimal models; Anti-beta2 glycoprotein I antibodies; Antiphospholipid syndrome; Complement; Inflammation; Miscarriages; Therapy; Thrombosis; Immunology and Allergy; ImmunologyTherapymedicine.symptomlcsh:RC581-607businessFrontiers in Immunology
researchProduct

Serological Levels of Anti-clathrin Antibodies Are Decreased in Patients With Pseudoexfoliation Glaucoma

2021

Evidence for immunologic contribution to glaucoma pathophysiology is steadily increasing in ophthalmic research. Particularly, an altered abundance of circulating autoantibodies to ocular antigens is frequently observed. Here, we report an analysis of autoantibody abundancies to selected antigens in sera of open-angle glaucoma patients, subdivided into normal-tension glaucoma (N = 31), primary open-angle glaucoma (N = 43) and pseudoexfoliation glaucoma (N = 45), vs. a non-glaucomatous control group (N = 46). Serum samples were analyzed by protein microarray, including 38 antigens. Differences in antibody levels were assessed by ANOVA. Five serological antibodies showed significantly altered…

lcsh:Immunologic diseases. Allergy0301 basic medicineMicroarraygenetic structuresautoantibodiesImmunologyProtein Array AnalysisGlaucomamedicine.disease_causeExfoliation SyndromeAutoantigensSerologyAutoimmunityPathogenesis03 medical and health sciences0302 clinical medicineAntigenmedicineHumansImmunology and AllergyOriginal Researchbiologybusiness.industryautoimmunityAutoantibodyComputational Biologybioinformaticsmedicine.diseaseimmunoproteomicseye diseasesClathrin030104 developmental biologyglaucomaCase-Control StudiesImmunology030221 ophthalmology & optometrybiology.proteinsense organsDisease SusceptibilityAntibodylcsh:RC581-607businessmicroarrayBiomarkersGlaucoma Open-AngleFrontiers in Immunology
researchProduct

Autoantigens in the trabecular meshwork and glaucoma‐specific alterations in the natural autoantibody repertoire

2019

Abstract Objectives Primary open‐angle glaucoma (POAG) is a neurodegenerative disorder leading to a gradual vision loss caused by progressive damage to the optic nerve. Immunological processes are proposed to be involved in POAG pathogenesis. Altered serological autoantibody levels have been frequently reported, but complete analyses of the natural autoantibodies with respect to disease‐related alterations are scarce. Here, we provide an explorative analysis of pathways and biological processes that may involve naturally immunogenic proteins and highlight POAG‐specific alterations. Methods Mass spectrometry‐based antibody‐mediated identification of autoantigens (MS‐AMIDA) was carried out in…

lcsh:Immunologic diseases. Allergy0301 basic medicinegenetic structuresImmunologyGlaucomaPDGFRBBiologymedicine.disease_causeAutoimmunityPathogenesis03 medical and health sciences0302 clinical medicineAntigenmedicineImmunology and AllergyGeneral Nursingtrabecular meshworkAutoantibodymedicine.diseaseimmunoproteomicsautoantigeneye diseasesglaucoma030104 developmental biologymedicine.anatomical_structureImmunologybiomarkerBiomarker (medicine)Original Articlenatural autoantibodiessense organsTrabecular meshworklcsh:RC581-607030217 neurology & neurosurgeryClinical & Translational Immunology
researchProduct